Lumos Pharma (LUMO) Q3 2024 Earnings

7NovConfirmed
Q4 2023
Q2 2024
Q3 2024
Q3 2024
-1.29
-1.13
-0.98
-0.82

Details

Expected EPS
-0.82
Actual EPS
-0.9
Surprise EPS
-0.08
Surprise Percent
+9.76%

Description

Lumos Pharma (LUMO) has reported earnings of -0.9 per share for Q3 2024.

0 Comments

Share your thoughts